Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium

Blood

Volumn 114, Issue 25, 2009, Pages 5225-5235

  Pham, Tho ^a   Gregg, Christopher J ^a,b   Karp, Felix ^c   Chow, Renee ^c   Padler Karavani, Vered ^a,d   Cao, Hongzhi ^e   Chen, Xi ^e   Witztum, Joseph L ^b,f   Varki, Nissi M ^a,c   Varki, Ajit ^a,b,d,f  

^a University of California San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; N GLYCOLOYLNEURAMINIC ACID; SELECTIN; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; N (O ACETYL)GLYCOLOYLNEURAMINIC ACID; N-(O-ACETYL)GLYCOLOYLNEURAMINIC ACID; SIALIC ACID DERIVATIVE;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHERENCE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; XENOBIOTIC METABOLISM; ANIMAL; ATHEROSCLEROSIS; BINDING COMPETITION; BLOOD; BLOOD VESSEL; CELL CULTURE; CELL LINE; CHICKEN; COLON; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; MALE; METABOLISM; PLACENTA; PREGNANCY; VASCULARIZATION;

ANIMALS; ANTIBODIES; ATHEROSCLEROSIS; BINDING, COMPETITIVE; BLOOD VESSELS; CELL LINE; CELLS, CULTURED; CHICKENS; COLON; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PLACENTA; PREGNANCY; SIALIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73949116790     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-220400     Document Type: Article

References (50)

1. Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007;446(7139):1023-1029.
2. Hayakawa T, Satta Y, Gagneux P, Varki A, Takahata N. Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene. Proc Natl Acad Sci U S A. 2001;98(18): 11399-11404.
3. Hedlund M, Tangvoranuntakul P, Takematsu H, et al. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol. 2007;27(12):4340-4346.
4. Diaz SL, Padler-Karavani V, Ghaderi D, et al. Sensitive and specific detection of the nonhuman sialic acid N-glycolylneuraminic acid in human tissues and biotherapeutic products. PLoS ONE. 2009;4(1):e4241.
5. Bardor M, Nguyen DH, Diaz S, Varki A. Mechanism of uptake and incorporation of the nonhuman sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem. 2005;280(6):4228-4237.
6. Nguyen DH, Tangvoranuntakul P, Varki A. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J Immunol. 2005;175(1):228-236.
7. Yin J, Hashimoto A, Izawa M, et al. Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res. 2006;66(6):2937-2945.
8. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A. 2003;100(21):12045-12050.
9. Finch CE, Stanford CB. Meat-adaptive genes and the evolution of slower aging in humans. Q Rev Biol. 2004;79(1):3-50.
10. Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004;80(4):1029-1035.
11. Schulze MB, Hoffmann K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005;82(3): 675-684, quiz 714-715.
12. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr. 2007;137(4):992-998.
13. Malykh YN, Schauer R, Shaw L. N-glycolylneuraminic acid in human tumours. Biochimie. 2001; 83(7):623-634.
14. Beer P. The heterophile antibodies in infectious mononucleosis and after injection of serum. J Clin Invest. 1936;15(6):591-599.
15. Morito T, Kano K, Milgrom F. Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases. J Immunol. 1982;129(6): 2524-2528.
16. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation. 2002;9(6):376-381.
17. Padler-Karavani V, Yu H, Cao H, et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology. 2008; 18(10):818-830.
18. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008; 109(4):e102-e107.
19. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull. 2004;70:71-86.
20. Pall AA, Savage CO. Mechanisms of endothelial cell injury in vasculitis. Springer Semin Immunopathol. 1994;16(1):23-37.
21. Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol. 2000; 190(3):349-359.
22. Guilpain P, Mouthon L. Antiendothelial cells auto-antibodies in vasculitis-associated systemic diseases. Clin Rev Allergy Immunol. 2008;35(1-2): 59-65.
23. Navarro M, Cervera R, Font J, et al. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus. 1997;6(6):521-526.
24. Meroni P, Ronda N, Raschi E, Borghi MO. Humoral autoimmunity against endothelium: theory or reality? Trends Immunol. 2005;26(5):275-281.
25. Gobel U, Eichhorn J, Kettritz R, et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis. 1996;28(2):186-194.
26. Jamin C, Dugue C, Alard JE, et al. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum. 2005;52(12):4028-4038.
27. Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schonlein purpura. Clin Exp Immunol. 2002; 130(2):352-357.
28. Perry GJ, Elston T, Khouri NA, Chan TM, Cameron JS, Frampton G. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage. Q J Med. 1993;86(11):727-734.
29. Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int. 2000;20(1):1-7.
30. Matsuo S, Fukatsu A, Taub ML, Caldwell PR, Brentjens JR, Andres G. Glomerulonephritis induced in the rabbit by antiendothelial antibodies. J Clin Invest. 1987;79(6):1798-1811.
31. Binder CJ, Shaw PX, Chang MK, et al. The role of natural antibodies in atherogenesis. J Lipid Res. 2005;46(7):1353-1363.
32. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15(10):1569-1576.
33. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993;341(8840): 255-259.
34. Zhu J, Katz RJ, Quyyumi AA, et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation. 2004;109(1):36-41.
35. Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361-403.
36. Perschinka H, Wellenzohn B, Parson W, et al. Identification of atherosclerosis-associated conformational heat shock protein 60 epitopes by phage display and structural alignment. Atherosclerosis. 2007;194(1):79-87.
37. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum. 2001;44(7):1484-1494.
38. Del Papa N, Conforti G, Gambini D, et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol. 1994;70(3):211-216.
39. Brock TG, McNish RW, Coffey MJ, Ojo TC, Phare SM, Peters-Golden M. Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J Immunol. 1996;156(7):2522-2527.
40. Delneste Y, Charbonnier P, Herbault N, et al. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood. 2003;101(1):143-150.
41. Palinski W, Yla-Herttuala S, Rosenfeld ME, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990; 10(3):325-335.
42. Nguyen DH, Hurtado-Ziola N, Gagneux P, Varki A. Loss of Siglec expression on T lymphocytes during human evolution. Proc Natl Acad Sci U SA. 2006;103(20):7765-7770.
43. Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest. 1996;98(8):1699-1702.
44. Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation. 1996;20(1): 1-9.
45. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 1994;94(3):1147-1155.
46. Takano M, Meneshian A, Sheikh E, et al. Rapid upregulation of endothelial P-selectin expression via reactive oxygen species generation. Am J Physiol Heart Circ Physiol. 2002;283(5):H2054-H2061.
47. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 1990;343(6260): 757-760.
48. Hanasaki K, Varki A, Stamenkovic I, Bevilacqua MP. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha2,6-sialylation of adhesion molecules and CD22 ligands. J Biol Chem. 1994; 269(14):10637-10643.
49. Hedlund M, Padler-Karavani V, Varki NM, Varki A. Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc Natl Acad Sci U S A. 2008;105(48):18936-18941.
50. Benatuil L, Kaye J, Rich RF, Fishman JA, Green WR, Iacomini J. The influence of natural antibody specificity on antigen immunogenicity. Eur J Immunol. 2005;35(9):2638-2647.